RE: Align research29 Jun 2018 12:52
Hi Valju - that’s fair enough and point taken.
Questions: not to you directly Valju, but others.....
1. what do you think the average salary of a full time director of a small quoted company is?
2. How long do you think it takes from drug inception to commercialisation.
3. Do you think VAL’s corporate brokers completely mis-valued the company when it IPO’d?
4. Do you think you sjould have invested when the product line was more advanced?
5. As the last years have been R’n’D and test focussed and no income flow, apart from international fund raise (and note the costs are significantly cheaper than the +£250k of a rights), where were they supposed to get their money from?
6. Finally, if we were to pay the VAL team peanuts, don’t you think we would have a company brain drain and we might not have the progress we have had in the last 7 months?